270 related articles for article (PubMed ID: 8077931)
1. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection.
Balthesen M; Dreher L; Lucin P; Reddehase MJ
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2329-36. PubMed ID: 8077931
[TBL] [Abstract][Full Text] [Related]
2. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.
Reddehase MJ; Balthesen M; Rapp M; Jonjić S; Pavić I; Koszinowski UH
J Exp Med; 1994 Jan; 179(1):185-93. PubMed ID: 8270864
[TBL] [Abstract][Full Text] [Related]
3. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.
Steffens HP; Kurz S; Holtappels R; Reddehase MJ
J Virol; 1998 Mar; 72(3):1797-804. PubMed ID: 9499030
[TBL] [Abstract][Full Text] [Related]
4. Lungs are a major organ site of cytomegalovirus latency and recurrence.
Balthesen M; Messerle M; Reddehase MJ
J Virol; 1993 Sep; 67(9):5360-6. PubMed ID: 8394453
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection.
Polić B; Hengel H; Krmpotić A; Trgovcich J; Pavić I; Luccaronin P; Jonjić S; Koszinowski UH
J Exp Med; 1998 Sep; 188(6):1047-54. PubMed ID: 9743523
[TBL] [Abstract][Full Text] [Related]
6. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection.
Podlech J; Holtappels R; Pahl-Seibert MF; Steffens HP; Reddehase MJ
J Virol; 2000 Aug; 74(16):7496-507. PubMed ID: 10906203
[TBL] [Abstract][Full Text] [Related]
7. T-lymphocyte effects on murine cytomegalovirus pulmonary infection.
Kadima-Nzuji M; Craighead JE
Am J Pathol; 1990 Oct; 137(4):907-12. PubMed ID: 2171343
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation.
Podlech J; Holtappels R; Wirtz N; Steffens HP; Reddehase MJ
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2099-104. PubMed ID: 9747717
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of murine cytomegalovirus disease does not prevent latent virus infection.
Katzenstein DA; Crane RT; Jordan MC
J Lab Clin Med; 1986 Aug; 108(2):155-60. PubMed ID: 3016127
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus.
Okada K; Tanaka K; Noda S; Okazaki M; Koga Y
Arch Virol; 1999; 144(12):2273-90. PubMed ID: 10664384
[TBL] [Abstract][Full Text] [Related]
11. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus.
Koffron AJ; Mueller KH; Kaufman DB; Stuart FP; Patterson B; Abecassis MI
Scand J Infect Dis Suppl; 1995; 99():61-2. PubMed ID: 8668944
[TBL] [Abstract][Full Text] [Related]
13. Pediatric roots of cytomegalovirus recurrence and memory inflation in the elderly.
Adler SP; Reddehase MJ
Med Microbiol Immunol; 2019 Aug; 208(3-4):323-328. PubMed ID: 31062089
[TBL] [Abstract][Full Text] [Related]
14. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification.
Klotman ME; Henry SC; Greene RC; Brazy PC; Klotman PE; Hamilton JD
J Infect Dis; 1990 Feb; 161(2):220-5. PubMed ID: 2153738
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts.
Riddell SR
Semin Respir Infect; 1995 Dec; 10(4):199-208. PubMed ID: 8668847
[TBL] [Abstract][Full Text] [Related]
16. Evidence against a key role for transforming growth factor-beta1 in cytomegalovirus-induced bone marrow aplasia.
Dobonici M; Podlech J; Steffens HP; Maiberger S; Reddehase MJ
J Gen Virol; 1998 Apr; 79 ( Pt 4)():867-76. PubMed ID: 9568983
[TBL] [Abstract][Full Text] [Related]
17. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
Yuhasz SA; Dissette VB; Cook ML; Stevens JG
Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic cell stimulation enhances cytomegalovirus replication in the early period of primary infection in an experimental rat model.
Tamura K; Oka T; Ohsawa K; Koji T; Watanabe Y; Katamine S; Sato H; Ayabe H
J Heart Lung Transplant; 2003 Apr; 22(4):452-9. PubMed ID: 12681423
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific control of latent CMV reactivation by regulatory T cells.
Almanan M; Raynor J; Sholl A; Wang M; Chougnet C; Cardin RD; Hildeman DA
PLoS Pathog; 2017 Aug; 13(8):e1006507. PubMed ID: 28796839
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression reactivates and disseminates latent murine cytomegalovirus.
Jordan MC; Shanley JD; Stevens JG
J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
